Escitalopram (Cipralex Meltz, Cipralex -20mg) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 13, 2026
Some Escitalopram products are in shortage in Canada (3 of 41 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
An antidepressant (SSRI) used to treat depression and anxiety disorders.
Products affected
3 / 41
In shortage since
Sep 9, 2025
Est. full return
Aug 7, 2026
Reports on file
169
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ACH-ESCITALOPRAM
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434652 · since ?, est. end Aug 7, 2026 · Demand increase for the drug.
Active shortage
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · since Jun 17, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
ESCITALOPRAM
20MG · TABLET · SANIS HEALTH INC
DIN 02430126 · since Sep 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Anticipated
ESCITALOPRAM
10MG · TABLET · SANIS HEALTH INC
DIN 02430118 · Disruption of the manufacture of the drug.
Anticipated
TEVA-ESCITALOPRAM
10MG · TABLET · TEVA CANADA LIMITED
DIN 02318180 · Disruption of the manufacture of the drug.
Resolved
ACH-ESCITALOPRAM
20MG · TABLET · ACCORD HEALTHCARE INC
DIN 02434660 · ended Jul 9, 2026 · Demand increase for the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 9, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Jun 10, 2026 · Disruption of the manufacture of the drug.
Discontinued
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251
Resolved
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-ESCITALOPRAM
20MG · TABLET · PHARMASCIENCE INC
DIN 02469251 · ended May 4, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ESCITALOPRAM
20MG · TABLET · TEVA CANADA LIMITED
DIN 02318202 · ended Mar 25, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Escitalopram is currently affected by 3 active shortage reports filed with Health Canada by ACCORD HEALTHCARE INC, TEVA CANADA LIMITED, SANIS HEALTH INC.
The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Escitalopram is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Jul 13, 2026
Estimated end date moved earlier : null → Sep 25, 2026
Jul 10, 2026
Estimated end date pushed back : Jul 17, 2026 → Aug 7, 2026
Jul 10, 2026
Shortage resolved
Common questions
What is Escitalopram used for?
An antidepressant (SSRI) used to treat depression and anxiety disorders.
When will Escitalopram be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Escitalopram in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.